Current Issue February 2012, Vol. 9, No. 2

Featured Article

Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators free full text

Free Press Article

Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation free full text

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be life-saving for some patients, the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRS) have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies.
Read the full article

Sex Hormones and Ventricular Tachyarrhythmias in LQTS: New Insights Regarding Antiarrhythmic Therapy
20 January 2012
Arthur J. Moss
- PDF (273 KB)
The Riata Story—Where are we now?
16 January 2012
Charles A. Henrikson
- PDF (202 KB)
Ranolazine stabilizes cardiac Ryanodine receptors: a novel mechanism for the suppression of Early afterdepolarization and Torsade de Pointes in Long QT type 2
13 January 2012
Ashish Parikh, Rajkumar Mantravadi, Dmitry Kozhevnikov, Michael A. Roche, Yanping Ye, Laura J. Owen, Jose Luis Puglisi, Jonathan J. Abramson, Guy Salama
Abstract: Background: Ranolazine (Ran) is known to inhibit multiple targets, including: the late Na+ current, INa, the rapid delayed rectifying K+ current IKr, L-type Ca2+ current ICa,L, and fatty-aci...
Letter to the Editor - Advice for “Proud Flesh” Post Permanent Pacemaker
13 January 2012
Victor Parsonnet
- PDF (129 KB)
Advice for "Proud Flesh" Post Permanent Pacemaker article Author reply
13 January 2012
Siddharth A. Kakodkar, Richard G. Trohman
- PDF (220 KB)

View More Articles in Press...

Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies
September 2011 (Vol. 8 | No. 9 | Pages 1444-1451)
Jason G. Andrade, Paul Khairy, Peter G. Guerra, Marc W. Deyell, Lena Rivard, Laurent Macle, Bernard Thibault, Mario Talajic, Denis Roy, Marc Dubuc
HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011
August 2011 (Vol. 8 | No. 8 | Pages 1340-1356)
Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher, Sumeet S. Chugh
- Full Text
- PDF (585 KB)
Smoking and incidence of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) Study
August 2011 (Vol. 8 | No. 8 | Pages 1160-1166)
Alanna M. Chamberlain, Sunil K. Agarwal, Aaron R. Folsom, Sue Duval, Elsayed Z. Soliman, Marietta Ambrose, Lynn E. Eberly, Alvaro Alonso
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
January 2011 (Vol. 8 | No. 1 | Pages 157-176)
L. Samuel Wann, Anne B. Curtis, Craig T. January, Kenneth A. Ellenbogen, James E. Lowe, N.A. Mark Estes, Richard L. Page, Michael D. Ezekowitz, David J. Slotwiner, Warren M. Jackman, William G. Stevenson, Cynthia M. Tracy
- Full Text
- PDF (1442 KB)
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
August 2011 (Vol. 8 | No. 8 | Pages 1308-1339)
Michael J. Ackerman, Silvia G. Priori, Stephan Willems, Charles Berul, Ramon Brugada, Hugh Calkins, A. John Camm, Patrick T. Ellinor, Michael Gollob, Robert Hamilton, Ray E. Hershberger, Daniel P. Judge, Hervè Le Marec, William J. McKenna, Eric Schulze-Bahr, Chris Semsarian, Jeffrey A. Towbin, Hugh Watkins, Arthur Wilde, Christian Wolpert, Douglas P. Zipes
- Full Text
- PDF (1134 KB)

Most Read lists are compiled every quarter.

Current Issue

New Issue Alert

Free Trial Issue

Journal Ranking

About the Journal

HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, provides rapid online and print publication of the most important basic and clinical scientific developments devoted to arrhythmias, devices and cardiovascular electrophysiology. The Journal is the only EP publication serving the entire electrophysiology community from basic to clinical academic researchers, private practitioners, allied health professionals, industry and trainees.

Publishing Information

Heart Rhythm is published by Elsevier for the Heart Rhythm Society

Access this journal onSciVerse ScienceDirect

Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias

Video--flashvideo1hrthm--http://podcasts.elsevierhealth.com/hrthm/hrthm_PIIS1547527110004054_mmc3.flv--/webfiles/images/journals/hrthm/video.gifhealthadvance--1547-5271--15.00--hp_10012010_V1--www.heartrhythmjournal.com

Basic and Translational

More

Clinical

More

About HRS

Heart Rhythm Society is the only national membership organization dedicated to informing health professionals and their patients about heart rhythm disorders, cardiac arrhythmias, cardiac death, and their treatments. Through research, education, and clinical practice, Heart Rhythm Society provides life-enhancing heart rhythm management and advances the highest standards of patient care.